Taysha Gene Therapies Inc. (TSHA) Social Stream
TAYSHA GENE THERAPIES INC (TSHA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TSHA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $60 | $34 | $45.6 | $1.82 | 2405.49% |
| 2021-11-11 | 11 | $60 | $33 | $44.9 | $1.82 | 2367.03% |
| 2022-01-27 | 12 | $60 | $28 | $43.363 | $1.82 | 2282.58% |
| 2022-01-31 | 12 | $60 | $28 | $42.545 | $1.82 | 2237.64% |
| 2022-03-01 | 13 | $60 | $25 | $41.083 | $1.82 | 2157.31% |
| 2022-03-09 | 14 | $60 | $25 | $39.923 | $1.82 | 2093.57% |
| 2022-04-04 | 14 | $45 | $22 | $32.923 | $1.82 | 1708.96% |
| 2022-05-17 | 14 | $45 | $22 | $32.076 | $1.82 | 1662.42% |
| 2022-05-19 | 14 | $45 | $9 | $30.846 | $1.82 | 1594.84% |
| 2022-05-24 | 15 | $45 | $9 | $29.785 | $1.82 | 1536.54% |
| 2022-08-12 | 11 | $38 | $9 | $26.272 | $1.82 | 1343.52% |
| 2022-08-15 | 10 | $38 | $16 | $27.8 | $1.82 | 1427.47% |
| 2022-10-26 | 10 | $38 | $15 | $24.4 | $1.82 | 1240.66% |
| 2022-11-08 | 11 | $38 | $15 | $23.636 | $1.82 | 1198.68% |
| 2022-11-09 | 11 | $38 | $15 | $22.909 | $1.82 | 1158.74% |
| 2022-11-14 | 12 | $23 | $3 | $16.083 | $1.82 | 783.68% |
| 2022-12-21 | 12 | $24 | $3 | $16.692 | $1.82 | 817.14% |
| 2023-01-04 | 12 | $24 | $3 | $16.384 | $1.82 | 800.22% |
| 2023-01-30 | 12 | $24 | $3 | $14.846 | $1.82 | 715.71% |
| 2023-02-01 | 13 | $19 | $1.5 | $7.961 | $1.82 | 337.42% |
| 2023-03-29 | 12 | $19 | $1.5 | $7.961 | $1.82 | 337.42% |
| 2023-03-30 | 12 | $19 | $0.7 | $6.746 | $1.82 | 270.66% |
| 2023-05-12 | 11 | $19 | $0.7 | $7.225 | $1.82 | 296.98% |
| 2023-08-15 | 11 | $19 | $2 | $8 | $1.82 | 339.56% |
| 2023-08-16 | 11 | $19 | $2 | $7.666 | $1.82 | 321.21% |
| 2023-09-20 | 11 | $19 | $2 | $7.333 | $1.82 | 302.91% |
| 2023-09-21 | 11 | $19 | $2 | $7.25 | $1.82 | 298.35% |
| 2023-10-24 | 10 | $19 | $2 | $7.409 | $1.82 | 307.09% |
| 2023-11-15 | 10 | $8 | $2 | $5.5 | $1.82 | 202.2% |
| 2023-11-16 | 10 | $7.5 | $2 | $5.5 | $1.82 | 202.2% |
The Trend in the Analyst Price Target
TSHA's average price target has moved down $11.19 over the prior 47 weeks.
TSHA reports an average of 556.35% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 12 | 19.0 | 1.5 | 7.961 | 1.210 | 557.93% |
| 2023-03-30 | 12 | 19.0 | 0.7 | 6.746 | 0.724 | 831.77% |
| 2023-09-21 | 11 | 19.0 | 2.0 | 7.636 | 3.030 | 152.01% |
| 2023-09-21 | 10 | 19.0 | 2.0 | 7.636 | 3.030 | 152.01% |
| 2023-11-15 | 10 | 7.5 | 2.0 | 5.388 | 1.680 | 220.71% |
TSHA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 7 | 1 | 2 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 23 months, TSHA's average broker recommendation rating worsened by 0.33.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TSHA as an investment opportunity.
- In terms of how TAYSHA GENE THERAPIES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 4032.49% of that group.
- TSHA has a lower variance in analysts' estimates than -3791.26% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, TAYSHA GENE THERAPIES INC's number of analysts covering the stock is higher than 4238.49% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, TAYSHA GENE THERAPIES INC's average analyst price target is higher than 2089.98% of them.
Stocks similar to TAYSHA GENE THERAPIES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OPT, TARS, and ALGS.
View All Top Stocks by Price Target
Make investment decisions regarding TSHA using the data that counts. Try POWR Ratings for free.